Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Open in API
Filings indexed 1,332 across all filing types
Latest filing 2018-01-31 Transaction in Own Shar…
Country DK Denmark
Listing CO AMBU

About Ambu

https://www.ambu.com

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Ambu A/S: Share buyback to cover incentive programmes
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement regarding a share buyback program initiated by Ambu. It details the number of shares to be repurchased, the purpose (to cover incentive programs), the regulatory framework (Safe Harbour rules), and the timeline. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers share buybacks.
2018-01-31 English
Ambu A/S: Share buyback to cover incentive programmes
Transaction in Own Shares Classification · 100% confidence The document is a short announcement (716 characters) regarding the initiation of a share buyback program by Ambu A/S to cover incentive programs. It explicitly mentions the purpose of the buyback and provides a link to the full company announcement. Since it describes the company buying back its own shares, it falls under the 'Transaction in Own Shares' category.
2018-01-31 English
Regulatory Filings 2018
Regulatory Filings Classification · 92% confidence The document is a press release written in Danish announcing that Ambu has received FDA approval for a single-use colonoscope in the USA ahead of schedule. It discusses a significant business milestone, the impact on the US market, a related milestone payment, and confirms that the financial guidance remains unchanged. This type of announcement, detailing a specific regulatory achievement, product launch preparation, and its immediate financial/operational consequence, is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were tied to a specific reporting period's results. However, since it is a specific, non-periodic announcement about a regulatory event (FDA approval) and not a comprehensive financial report (like 10-K or IR) or a management discussion (MDA), the most appropriate general category for such specific, non-standard corporate news is Regulatory Filings (RNS), which serves as a broad category for regulatory updates that don't fit elsewhere. Given the content is a direct announcement of a regulatory event and business update, RNS is the best fit among the provided options, as it is not a standard ER, CT, or IR.
2018-01-10 Danish
Regulatory Filings 2018
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Ambu has received FDA clearance for its disposable colonoscope in the US. It discusses the market potential, quotes the CEO, mentions a milestone payment, and provides background on single-use endoscopy technology. This type of announcement, focusing on a specific operational or regulatory achievement rather than comprehensive financial results (10-K, IR, ER) or management changes (MANG), best fits the category for general regulatory or operational news that doesn't fit a more specific financial or corporate governance code. Since it is a specific operational/regulatory update that is not a standard financial report, dividend notice, or insider trade, it falls under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for significant, non-standard announcements.
2018-01-10 English
Ambu A/S: Aktiesplit
Share Issue/Capital Change Classification · 100% confidence The document is an official company announcement regarding a stock split (aktiesplit) for Ambu A/S. It details the change in share denomination from 2.50 DKK to 0.50 DKK and the resulting increase in the number of shares, which falls under capital structure changes. According to the provided definitions, announcements regarding stock splits are classified as 'Share Issue/Capital Change' (SHA).
2017-12-18 English
Ambu A/S: Aktiesplit
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Ambu A/S regarding a stock split ('Aktiesplit'). It details the change in share denomination from 2.50 DKK to 0.50 DKK, the resulting split ratio, and the change in the ISIN code. This falls under the category of capital changes or share structure adjustments, which is explicitly covered by the 'SHA' (Share Issue/Capital Change) category.
2017-12-18 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.